EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC 4.0

The Role of Price Variation in Economic Analyses for Cancer Screenings: A Rapid Review

Austin J Triana iD, Mason N Alford-Holloway

Applied Health Economics and Health Policy · 2026-03 · 24 (2) · 287-292

DOI: 10.1007/s40258-025-01007-1 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Applied Health Economics and Health Policy, online erschienen am 07.10.2025. Verfasst von Austin J Triana und 1 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt University Medical Center, Nashville, TN, USA. austin.j.triana@gmail.com. Hauptthemen laut MEDLINE: Early Detection of Cancer, Cost-Benefit Analysis, Neoplasms. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Health care spending continues to rise, and recent policies have made prices more visible. PURPOSE: To assess how cost effectiveness analyses obtain price information for common cancer screenings and account for price variation. METHODS: A systematic search of PUBMED was conducted, extracting studies from 2021 to 2024 in English and evaluating health care services in the USA. Cost-effectiveness analyses were included for four common cancer screenings: prostate cancer, breast cancer, colon cancer, and lung cancer. A single investigator extracted data and assessed quality, reviewed by a second investigator. RESULTS: A total of 16 articles met inclusion criteria. Nearly all (94%) cited the Medicare Fee Schedule as the data source for pricing information. About half (44%) of analyses included a degree of price variation. Only three articles (19%) performed a cost-effectiveness analysis with a wide degree of price variation that accurately reflected the true degree of price variation observed in empirical data. LIMITATIONS: The sample size of included studies was modest, and generalizability is limited beyond these four common cancer screenings. CONCLUSIONS: Cost-effectiveness analyses in the USA need to reflect the wide price variation that exists in health care, and publicly available price transparency data should guide future work.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Early Detection of CancerCost-Benefit AnalysisNeoplasmsHumansUnited StatesProstatic NeoplasmsBreast NeoplasmsMedicareMaleFemale

Autor:innen und Institutionen

  • Vanderbilt University Medical Center, Nashville, TN, USA. austin.j.triana@gmail.com.
  • University of Pennsylvania Health System, Philadelphia, PA, USA. austin.j.triana@gmail.com.
  • Vanderbilt University Medical Center, Nashville, TN, USA.

ORCID-Profile: Austin J Triana

Zitieren

APA

Triana, A. J., & Alford-Holloway, M. N. (2026). The Role of Price Variation in Economic Analyses for Cancer Screenings: A Rapid Review. Applied Health Economics and Health Policy, 24(2), 287-292. https://doi.org/10.1007/s40258-025-01007-1

Vancouver

Triana AJ, Alford-Holloway MN. The Role of Price Variation in Economic Analyses for Cancer Screenings: A Rapid Review. Applied Health Economics and Health Policy. 2026;24(2):287-292. doi:10.1007/s40258-025-01007-1

BibTeX
@article{Triana2026,
  author = {Triana, Austin J and Alford-Holloway, Mason N},
  title = {The Role of Price Variation in Economic Analyses for Cancer Screenings: A Rapid Review},
  journal = {Applied Health Economics and Health Policy},
  year = {2026},
  volume = {24},
  number = {2},
  pages = {287--292},
  doi = {10.1007/s40258-025-01007-1}
}
Kostenlos starten →